# Genetic Mutations and Non-Genomic Dysregulation in Human Preimplantation Embryo Arrest

**Authors:** Jianan Jiang, Junhua Peng, Lin Li, Min Xu

PMC · DOI: 10.3390/ijms27052135 · International Journal of Molecular Sciences · 2026-02-25

## TL;DR

This paper reviews the genetic and non-genetic factors causing embryo arrest during early human development.

## Contribution

It categorizes molecular mechanisms behind embryo arrest into genetic and unexplained causes.

## Key findings

- Genetic mutations disrupt maternal mRNA clearance, spindle assembly, and cell cycle checkpoints.
- Unexplained cases show multi-omics abnormalities like DNA hypermethylation and chromosomal aneuploidy.
- Most clinical cases of embryo arrest remain genetically unexplained.

## Abstract

Human preimplantation embryo arrest (PREMBA) represents a significant clinical hurdle in assisted reproductive technology (ART), in which approximately 10% of in vitro fertilized (IVF) embryos arrest at the cleavage stages. Whole-exome sequencing (WES) studies have discovered numerous genetic mutations associated with preimplantation embryo arrest. These mutations often disrupt critical biological milestones such as maternal mRNA clearance (BTG4, ZFP36L2, ZAR1), subcortical maternal complex (TLE6, PADI6, OOEP, NLRP2, NLRP5, NLRP7, KHDC3L), DNA double-strand break formation and homologous recombination (REC114, TOP6BL, MEI1, MEI4, TRIP13), spindle assembly (TUBB8 and TUBA4A) and cell cycle and checkpoints (FBXO43, MOS, CHEK1, TRIP13, CDC20), as well as nuclear transport and translational regulation (KPNA7, DDOST). However, the cause of most clinical cases remains genetically unexplained. Studies investigating these unexplained arrests have uncovered widespread multi-omics abnormalities, including transcriptional arrest, DNA hypermethylation, higher chromatin accessibility, aberrant histone modification, chromosomal aneuploidy and senescent-like states. This review provides a comprehensive overview of the molecular mechanisms underlying PREMBA, categorized into those that are attributable to known genetic mutations and those with unexplained reasons.

## Linked entities

- **Genes:** BTG4 (BTG anti-proliferation factor 4) [NCBI Gene 54766], ZFP36L2 (ZFP36 like 2 zinc finger CCCH-type) [NCBI Gene 678], ZAR1 (zygote arrest 1) [NCBI Gene 326340], TLE6 (TLE family member 6, subcortical maternal complex member) [NCBI Gene 79816], PADI6 (peptidyl arginine deiminase 6) [NCBI Gene 353238], OOEP (oocyte expressed protein) [NCBI Gene 441161], NLRP2 (NLR family pyrin domain containing 2) [NCBI Gene 55655], NLRP5 (NLR family pyrin domain containing 5) [NCBI Gene 126206], NLRP7 (NLR family pyrin domain containing 7) [NCBI Gene 199713], KHDC3L (KH domain containing 3 like, subcortical maternal complex member) [NCBI Gene 154288], REC114 (REC114 meiotic recombination protein) [NCBI Gene 283677], TOP6BL (TOP6B like initiator of meiotic double strand breaks) [NCBI Gene 79703], MEI1 (meiotic double-stranded break formation protein 1) [NCBI Gene 150365], MEI4 (meiotic double-stranded break formation protein 4) [NCBI Gene 101928601], TRIP13 (thyroid hormone receptor interactor 13) [NCBI Gene 9319], TUBB8 (tubulin beta 8 class VIII) [NCBI Gene 347688], TUBA4A (tubulin alpha 4a) [NCBI Gene 7277], FBXO43 (F-box protein 43) [NCBI Gene 286151], MOS (MOS proto-oncogene, serine/threonine kinase) [NCBI Gene 4342], CHEK1 (checkpoint kinase 1) [NCBI Gene 1111], CDC20 (cell division cycle 20) [NCBI Gene 991], KPNA7 (karyopherin subunit alpha 7) [NCBI Gene 402569], DDOST (dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit) [NCBI Gene 1650]

## Full-text entities

- **Genes:** TUBB8 (tubulin beta 8 class VIII) [NCBI Gene 347688] {aka OOMD, OOMD2, OZEMA2, bA631M21.2}, NLRP2 (NLR family pyrin domain containing 2) [NCBI Gene 55655] {aka CLR19.9, NALP2, NBS1, OZEMA18, PAN1, PYPAF2}, NLRP5 (NLR family pyrin domain containing 5) [NCBI Gene 126206] {aka CLR19.8, MATER, NALP5, OZEMA19, PAN11, PYPAF8}, KPNA7 (karyopherin subunit alpha 7) [NCBI Gene 402569] {aka IPOA8, OZEMA17}, OOEP (oocyte expressed protein) [NCBI Gene 441161] {aka C6orf156, FLOPED, HOEP19, KHDC2}, DDOST (dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit) [NCBI Gene 1650] {aka AGER1, CDG1R, GATD6, OKSWcl45, OST, OST48}, TRIP13 (thyroid hormone receptor interactor 13) [NCBI Gene 9319] {aka 16E1BP, MVA3, OOMD9, OZEMA9}, MEI1 (meiotic double-stranded break formation protein 1) [NCBI Gene 150365] {aka HYDM3, SPATA38}, MEI4 (meiotic double-stranded break formation protein 4) [NCBI Gene 101928601], TOP6BL (TOP6B like initiator of meiotic double strand breaks) [NCBI Gene 79703] {aka C11orf80, HYDM4, TOPOVIBL}, TLE6 (TLE family member 6, subcortical maternal complex member) [NCBI Gene 79816] {aka GRG6, OZEMA15, PREMBL}, REC114 (REC114 meiotic recombination protein) [NCBI Gene 283677] {aka C15orf60, CT147, OOMD10, OZEMA10}, ZAR1 (zygote arrest 1) [NCBI Gene 326340] {aka Z3CXXC6}, KHDC3L (KH domain containing 3 like, subcortical maternal complex member) [NCBI Gene 154288] {aka C6orf221, ECAT1, HYDM2}, MOS (MOS proto-oncogene, serine/threonine kinase) [NCBI Gene 4342] {aka MSV, OZEMA20}, PADI6 (peptidyl arginine deiminase 6) [NCBI Gene 353238] {aka OZEMA16, PREMBL2, hPADVI}, TUBA4A (tubulin alpha 4a) [NCBI Gene 7277] {aka ALS22, CMYO26, FTDALS9, H2-ALPHA, OZEMA23, SPAX11}, NLRP7 (NLR family pyrin domain containing 7) [NCBI Gene 199713] {aka CLR19.4, HYDM, NALP7, NOD12, OZEMA25, PAN7}, ZFP36L2 (ZFP36 like 2 zinc finger CCCH-type) [NCBI Gene 678] {aka BRF2, ERF-2, ERF2, OOMD13, OZEMA13, RNF162C}, CHEK1 (checkpoint kinase 1) [NCBI Gene 1111] {aka CHK1, OZEMA21}, BTG4 (BTG anti-proliferation factor 4) [NCBI Gene 54766] {aka APRO3, OOMD8, OZEMA8, PC3B}, FBXO43 (F-box protein 43) [NCBI Gene 286151] {aka EMI2, ERP1, FBX43, OOMD12, OZEMA12, SPGF64}, CDC20 (cell division cycle 20) [NCBI Gene 991] {aka CDC20A, OOMD14, OZEMA14, bA276H19.3, p55CDC}
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12984818/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12984818/full.md

## References

71 references — full list in the complete paper: https://tomesphere.com/paper/PMC12984818/full.md

---
Source: https://tomesphere.com/paper/PMC12984818